Information: This is an outdated version of the data model. You can find a Versions overview via Versions on the left. You can find the newest Version by clicking here.
Information:
Error:
ID
23219
Description
Phase II Study of AS1411 Combined With Cytarabine to Treat Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00512083
Link
https://clinicaltrials.gov/show/NCT00512083
Keywords
Versions (3)
- 6/29/17 6/29/17 -
- 1/10/18 1/10/18 - Julian Varghese
- 1/10/18 1/10/18 - Julian Varghese
Uploaded on
June 29, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Leukemia, Myeloid NCT00512083
Eligibility Leukemia, Myeloid NCT00512083
- StudyEvent: Eligibility
Similar models
Eligibility Leukemia, Myeloid NCT00512083
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
ID.1
Item
primary refractory or relapsed aml
boolean
C0278780 (UMLS CUI [1])
ID.2
Item
confirmed diagnosis of aml (de novo or secondary) as defined by who classification (vardiman 2002)
boolean
C0023467 (UMLS CUI [1,1])
C0011900 (UMLS CUI [1,2])
C0011900 (UMLS CUI [1,2])
ID.3
Item
aged at least 18 years
boolean
C0001779 (UMLS CUI [1])
ID.4
Item
initial diagnosis of acute promyelocytic leukemia as defined by french-american-british criteria (bennett 1976)
boolean
C0023487 (UMLS CUI [1])
ID.5
Item
patient in blast crisis stage of chronic myeloid leukemia
boolean
C0919644 (UMLS CUI [1])
ID.6
Item
received high-dose cytarabine (total cumulative dose of >6g/m sq)in last 6 months
boolean
C0010711 (UMLS CUI [1])
ID.7
Item
interval of <6 months between first onset of last complete remission and current relapse
boolean
C0677874 (UMLS CUI [1,1])
C0035020 (UMLS CUI [1,2])
C0035020 (UMLS CUI [1,2])
ID.8
Item
those with primary refractory leukemia who have received more than three previous induction cycles
boolean
C0857127 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
C0392920 (UMLS CUI [1,2])
ID.9
Item
relapsed patients who have received more than three previous treatment regimens
boolean
C0392920 (UMLS CUI [1])